nanogels containing Gd(III) or Dy(III) chelates were prepared and proposed as potential candidates for T1 and T2 MRI contrast agents. These samples exhibit remarkable chemical stability in biological fluids and demonstrate enhanced longitudinal and transverse relaxivity and MRI contrast when compared to commercially available probes, particularly at high magnetic field strengths.